Patent Application
Provisional
App. No. 62/882,813
· Confirmation No. 8384
Increasing Cancer Cells' Sensitivity to Tumor Treating Fields (TTFields) by Inhibiting IL11 Activity
Inventor:
Tali VOLOSHIN-SELA
Applicant:
Novocure GmbH
Provisional Application Expired
Inventors
Tali VOLOSHIN-SELA
Kibbutz Gvat, ISRAEL
Attorneys & Agents of Record
Prosecution
- Customer No.
- 162706
- Docket No.
- 1459-0068PV01
- Confirmation No.
- 8384
Child
Claims priority from a provisional application
→
App. 16/983,241
· US 12,343,336
Filed 2020-08-03
· Patented Case
Child
Claims priority from a provisional application
→
App. 18/820,642
Filed 2024-08-30
· Non Final Action Mailed
Child
Claims priority from a provisional application
→
App. 18/820,575
Filed 2024-08-30
· Non Final Action Mailed
Child
Claims priority from a provisional application
→
App. 18/820,688
Filed 2024-08-30
· Non Final Action Mailed
Child
Claims priority from a provisional application
→
App. 19/230,953
Filed 2025-06-06
· Docketed New Case - Ready for Examination
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 62/882,813
- Filed
- 2019-08-05
External Links